[1] Lai CC,Tan CK,Huang YT,et al.Current challenges in themanagement of invasive fungal infections[J].J Infect Chemoth-er,2008,14(2):77-85.
[2] Calderone R,Fonzi W.Virulence factors of Candida albicans[J].Trends Microbiol,2001,9(7):327-335.
[3] Julian R,Naglik,Stephen J,et al.Candida albicans secreted as-partyl proteinases in virulence and pathogenesis[J].MicrobiolMol Biol Rev,2003,67(3):400-428.
[4] Naglik JR,Moyes D,Makwana J,et al.Quantitative expressionof the Candida albicans secreted aspartyl proteinase gene familyin human oral and vaginal candidiasis[J].Microbiology,2008,154(11):3266-3280.
[5] Alexandra C,Ulrich L,Luzia T,et al.Limited role of secretedaspartyl proteinases Sap1 to Sap6 in Candida albicans virulenceand host immune response in murine hematogenously dissemina-ted candidiasis[J].Infect Immun,2010,78(11):4839-4849.
[6] Hube B,Naglik J.Candida albicans proteinase:resolving themystery of agene family[J].Microbiology,2001,147(8):1997-2005.
[7] Borelli C,Ruge E,Lee JH,et al.X-ray structures of Sap1 andSap5:structural comparison of the secreted aspartic proteinasesfrom Candida albicans[J].Proteins,2008,72(4):1308-1319.
[8] Staib P,Kretschmay M,Nichterlein T,et al.Host versus in vitrosignals and intrastrain allelic differences in the expression of aCandida albicans virulence gene[J].Mol Microbiol,2002,44(5):1351-1366.
[9] 陈凌,赵亮,陈贻锴.呼吸道感染中白假丝酵母菌的致病性与细胞外水解酶关系[J].微生物学杂志,2008,28(3):50-53.
[10] Cassone A,Tacconelli E,De Bernardis F,et al.Antiretroviraltherapy with protease inhibitors has an early,immune econstitu-tion-independent beneficial effect on Candida virulence and oralcandidiasis in human immunodeficiency virus-infected subjects[J].J Infect Dis,2002(185):188-195.
[11] Hu Y,Farah CS,Ashnum RB.Isolates of Candida albicans thatdiffer in virulence for mice elicit strain-specific antibody-media-ted protective responses[J].Microbes Infeet,2006,8(3):612-620.
[12] Sandini S,La Valle R,Deaglio S,et al.A highly immunogenicrecombinant and truncated protein of the secreted aspartic prote-ases family(rSap2t)of Candida albicans as a mucosal antican-didal vaccine[J].FEMS Immunol Med Microbiol,2011,62(2):215-224.
[13] Jayatilake JA,Samaranayake YH,Cheung LK,et al.Quanti-tative evaluation of tissue invasion by wild type,hyphal andSAP mutants of Candida albicans,and non-albicans Candidaspecies in reconstituted human oral epithelium[J].J Oral PatholMed,2006,35(8):484-491.
[14] Schaller M,Schackert C,Korting HC,et al.Invasion of Candidaalbicans correlates with expression of secreted aspartic proteina-ses during experimental infection of human epidermis[J].J In-vest Dermatol,2000,114(4):712-717.
[15] Villar CC,Kashleva H,Nobile C,et al.Mucosal tissue invasionby Candida albicans is associated with E-cadherin degradation,mediated by transcription factor Rim101p and protease Sap5p[J].Infect lmmun,2007,75(5):2126-2135.
[16] Murad AM,d＇Enfert C,Gaillardin C,et al.Transcript profilingin Candida albicans reveals new cellular functions for the tran-scriptional repressors CaTup1,CaMig1and CaNrg1[J].Mol Mi-crobiol,2001,42(4):981-993.
[17] Staib P,Lermann U,Bla-Warmuth J,et al.Tetracycline-induc-ible expression of individual secreted aspartic proteasesinCandida albicans allows isoenzyme-specific inhibitor screening[J].Antimicrob Agents Chemother,2008,52(1):146-156.
[18] Reuss O,Morschhauser J.A family of oligopeptide transportersis required for growth of Candida albicans on proteins[J].MolMicrobiol,2006,60(3):795-812.
[19] Tongchusak S,Leelayuwat C,Bmsie V,et al.In silieo predictionand immunological validation of common HLA-DRB1-restrictedT cell epitopes of Candida albicans secretory aspartyl proteinase2[J].Microbiol Immunol,2008,52(4):231-242.
[20] Degel B,Staib P,Rohrer S,et al.Cis-configured aziridines arenew pseudo-irreversible dual-mode inhibitors of Candidaalbicans secreted aspartyl proteinase 2[J].Chem Med Chem,2008,3(2):302-315.
[21] Schaller M,Korting HC,Borelli C,et al.Candida albicans se-creted aspartyl proteinases modify the epithelial cytokine re-sponse in an in vitro model of vaginal candidiasis[J].Infect lm-mun,2005,73(5):2758-2765.
[22] Srinivasan L,Kenneth J.Antibiotic susceptibility of Candida i-solates in a tertiary care hospital in Southern India[J].Indian JMed Microbiol,2006,24(1):80-81.
[23] Pfaller MA,Diekema DJ,Sheehan DJ.Interpretive breakpointsfor fluconazole and Candida revisited:a blueprint for the futureof antifungal susceptibility testing[J].Clin Microbiol Rev,2006,19(2):435-447.
[24] Cassone A.Fungal vaccines:real progress from real challenges[J].Lancet Infect Dis,2008,8(2):114-124.
[25] Vilanova M,Teixeira L,Caramalho I,et al.Protection againstsystemic candidiasis in mice immunized with secreted asparticproteinase 2[J].Immunology,2004,111(3):334-342. |
